Carlo, Maria I.
Voss, Martin H.
Motzer, Robert J.
Article History
First Online: 21 June 2016
Competing interests
: M.H.V. has been a consultant for Novartis, GlaxoSmithKline, Bayer, Calithera, and Natera and has received honoraria from Novartis and research funding from Brystol-Myers Squibb and Pfizer. R.J.M. has been a consultant for Pfizer, Novartis, and Eisai and has received research funding from Genentech, Brystol-Myers Squibb, Exelixis, Eisai, and GlaxoSmithKline. M.I.C. declares no competing interests.
Free to read: This content has been made available to all.